A Study of TAVO101 in Atopic Dermatitis Patients

Clinical trial NCT06176040 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06176040
Sponsor: Tavotek Biotherapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2024-03-15
Primary completion: 2025-03-15
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.